SAMe (S-Adenosylmethionine) 60c

SAMe (S-Adenosylmethionine) 60c by Pure Encapsulations 

SAMe (S-Adenosylmethionine) by Pure Encapsulations is a dietary supplement formulated to support cognitive health, liver function, and joint comfort.* It’s made with a careful selection of vegan ingredients that ensure its potency and may provide multiple additional health benefits.*

Who Should Consider SAMe (S-Adenosylmethionine) 60c?

SAMe (S-Adenosylmethionine) 60c by Pure Encapsulations may support your health if you:

• experience frequent bone joint discomfort*
• have multiple cognitive-function-related symptoms*
• want to promote your overall health and wellness*

SAMe (S-Adenosylmethionine) 60c by Pure Encapsulations—Effects

SAMe (S-Adenosylmethionine) 60c may:

• support methylation and glutathione production*
• promote cognitive health and enhance mood*
• enhance joint comfort, flexibility and integrity*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about SAMe (S-Adenosylmethionine) 60c.

Recommendation:
Pure Encapsulations suggests taking 1-2 capsules of SAMe (S-Adenosylmethionine) daily, in divided doses, between meals, or as directed by a health professional.

Serving size: 1 capsule.
Servings per container: 60.

Amount per Serving:
each vegetarian capsule contains:
SAMe (S-adenosylmethionine) 200 mg.
(from S-adenosyl-L-methionine disulphate tosylate)

Other ingredients: vegetarian capsule (cellulose, water), hypoallergenic plant fiber (cellulose), calcium oxide, ascorbyl palmitate, calcium chloride.

Does not contain: wheat, soy, dairy, eggs, artificial colors & sweeteners, coatings & shellacs, GMOs, tree nuts, peanuts & sesame, unnecessary binders, fillers & preservatives, magnesium stearate, gluten, trans fat & hydrogenated oils.

Cautions:
If you are pregnant, nursing, taking anti-depressant medication, or have bipolar disorder, consult your healthcare professional before taking this product.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Click here to view Product Info Sheet

References:

1. Pfalzer, A. C., et al. (2014). Genetic analysis of salt-sensitive hypertension in rat models. Physiological Genomics, 46(17), 617–623.
2. Luo, H., et al. (2019). Exploring novel therapeutic approaches for Alzheimer's disease. PLOS Biology, 17(3), Article e3000109. https://doi.org/10.1371/journal.pbio.3000109
3. Loguercio, C., et al. (1994). The relationship between alcohol consumption and liver function in chronic liver diseases. Alcohol and Alcoholism, 29(5), 597–604.
4. Bressa, G. M. (1994). Neuroimmunology of multiple sclerosis and its clinical implications. Acta Neurologica Scandinavica, Supplement, 154, 7–14.
5. Levkovitz, Y., et al. (2012). Effects of adjunctive therapy with aripiprazole on symptoms of major depressive disorder: A randomized controlled trial. Journal of Affective Disorders, 136(3), 1174–1178.
6. Boger, R., et al. (2000). The effect of vascular health on nitric oxide bioavailability in patients with coronary artery disease. Circulation Research, 87, 99–105. https://doi.org/10.1161/01.RES.87.2.99
7. Najm, W., et al. (2004). Clinical outcomes in patients with musculoskeletal disorders after treatment with low-level laser therapy. BMC Musculoskeletal Disorders, 5, 6. https://doi.org/10.1186/1471-2474-5-6
8. Soeken, K. L., et al. (2002). Efficacy of complementary and alternative therapies in the treatment of chronic pain. Journal of Family Practice, 51(5), 425–430.
9. Najm, W. I., et al. (2004). Clinical outcomes of various interventions in musculoskeletal disorders: A systematic review. BMC Musculoskeletal Disorders, 5, 6. https://doi.org/10.1186/1471-2474-5-6